Substituted heterocyclic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S254020, C514S338000, C514S340000, C514S342000, C544S367000, C544S368000, C544S369000, C546S268400, C546S269100, C546S270100

Reexamination Certificate

active

07026321

ABSTRACT:
Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.

REFERENCES:
patent: 4558129 (1985-12-01), Kluge et al.
patent: 4567264 (1986-01-01), Kluge et al.
patent: 4723014 (1988-02-01), Anderson et al.
patent: 4766125 (1988-08-01), Van Daele et al.
patent: 4820842 (1989-04-01), Anderson et al.
patent: 5112817 (1992-05-01), Fukazawa et al.
patent: 5204348 (1993-04-01), Fukazawa et al.
patent: 5405843 (1995-04-01), Fukazawa et al.
patent: 5472707 (1995-12-01), Samuels et al.
patent: 5506229 (1996-04-01), Dow et al.
patent: 5906988 (1999-05-01), Dow
patent: 6451798 (2002-09-01), Varkhedkar et al.
patent: 6552023 (2003-04-01), Zablocki et al.
patent: 6573264 (2003-06-01), Zablocki et al.
patent: 6638970 (2003-10-01), Elzein et al.
patent: 6677336 (2004-01-01), Zablocki et al.
patent: 6677343 (2004-01-01), Blackburn et al.
patent: 2003/0181352 (2003-09-01), Ibrahim et al.
patent: 0 268 273 (1988-05-01), None
patent: 0 363 212 (1990-04-01), None
patent: 0 407 780 (1991-01-01), None
patent: 0 483 392 (1992-06-01), None
patent: 03 141258 (1991-06-01), None
patent: WO 01/62749 (2001-08-01), None
patent: WO 02/32902 (2002-04-01), None
Berthold, R. et al ‘3-Aminopropoxyaryl derivatives’ CA 105:172505 (1986).
Fan, Y. et al ‘Syntheses of 1-(2-hydroxy-3-aryloxypropyl)-4-aryolpiperazines’ CA 108:5971 (1988).
U.S. Appl. No. 10/729,499, Jiang et al.
McCormick, et al. “Ranolazine: A Novel Metabolic Modulator for the Treatment of Angina”, Gen Pharmac., vol. 30, No. 5, pp. 639-645, (1998).
Suzuki T et al: “Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer.”, Journal of Chemistry, vol. 40, No. 13, 1997, pp. 2047-2052, XP000924067, the whole document, particularly p. 2049, table 2, compound 5.
Zacharowski K et al: “Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.” European Journal of Pharmacology, vol. 418, No. 1-2, Apr. 20, 2001, pp. 105-110, XP002215620, the whole document.
Lopaschuk G D: “Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism”, The American Journal of Cardiology, vol. 82, No. 5A, Sep. 3, 1997, pp. 14K-17K, XP002215621, the whole document.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3605526

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.